Early stage investment forum logo 2.jpg

The Early Stage Investment Forum (ESIF) is a key element of AusBiotech 2019 conference featuring short pitches from SMEs and research institutions (Universities, Medical Research Institutes, etc.) on early stage Biotech technology and projects covering areas such as:

  • Human therapeutics

  • Diagnostics

  • Medical devices

  • Digital health and;

  • Enabling technologies

The pitches will be made to an expert panel that will include international pharma representatives as well as VCs and early stage investors.

The forum will take place on Friday, 1 November at the AusBiotech 2019 national conference held at the Melbourne Convention & Exhibition Centre between 9.00am–12.30pm and is open to conference delegates.

Last year’s inaugural forum held at the AusBiotech 2018 conference was viewed as a success by the conference attendees, so we are looking forward to hosting an equally successful event at the 2019 conference.

BioCurate logo JV stack V4.png


To encourage, recognise and reward early stage technology and projects, BioCurate is offering a $7,000AUD prize to the best presenting team as voted by the panel of experts.

Conditions of entry:

  • Submissions are open to projects from research institutions or SMEs seeking early stage investment (pre-seed and early Series A);

  • Information included in the application process and presented on the day should be non-confidential;

  • Applications from Institutions with Technology Transfer or Research Commercialisation Offices should seek prior approval from the relevant technology transfer or commercialisation office;

  • Where relevant, applications are preferred from the associated technology transfer or commercialisation offices of the Institutions;

  • Companies seeking pre-seed, seed or series A investment and Institutions without technology transfer or commercialisation offices should apply directly;

  • Presenters will be allocated 7 minutes per presentation followed by questions and feedback from the panel;

  • Applications will be reviewed by an ESIF panel prior to selection of successful applicants for presenting at the AusBiotech 2019 Early Stage Investment Forum;

  • Successful applicants will be provided with a template for their presentation, with a limit of 5 slides (not including the title slide). The use of this template will be strictly enforced. Company or Institution branding may be included;

  • Successful applicants will be required to present on Friday 1 November between 9.00am–12.30pm and will receive 10% discount off their standard registration rate.

Submission process:

To be considered for a spot in the Early Stage Investment forum, you are required to answer 5 questions via the online portal. Before you log into the portal, it is recommended that you type up the answers to the questions in word, then cut and paste into the applicable boxes in the portal.


  1. Institution name

  2. Project title

  3. Project description (Maximum 300 words)

  4. What is the investment you are looking for? (Maximum 150 words)

  5. What will the investment be used for and what will be the outcome at the end of the investment? (Maximum 150 words)

 Deadline for submissions is Friday 20 September 2019 at 12:00 midnight AEST

Contact: For further information, please email events@ausbiotech.org or call +613 9828 1400.